Stroke affects 60,000 Canadians annually. Stroke survivors are often left with a variety of impairments that can affect sensation, movement, visuospatial function, language and/or cognition. The nature and severity of these impairments cannot necessarily be predicted from routine clinical tests of the brain such as computed tomography or magnetic resonance imaging. Thus, clinicians rely on physical examination techniques and observer based ordinal scales to quantify the nature of post-stroke impairments. These bedside clinical assessments are used to diagnose impairments, prognosticate on recovery and serve as outcome measures for clinical trials. Unfortunately, many of these scales suffer from issues with floor or ceiling effects, reliability and precision. Our team has spent the last decade designing and validating a number of quantitative robotic assessments of post-stroke upper extremity function using a bimanual exoskeleton. We aim to help better understand the impairments that result from stroke and their effect on recovery.
